Literature DB >> 14988178

Drug regulators study global treaty to tackle counterfeit drugs.

Liza Gibson.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14988178      PMCID： PMC1125287          DOI： 10.1136/bmj.328.7438.486-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  Hospital Audit as a Useful Tool in the Process of Introducing Falsified Medicines Directive (FMD) into Hospital Pharmacy Settings-A Pilot Study.

Authors:  Urszula Religioni; Damian Swieczkowski; Anna Gawrońska; Anna Kowalczuk; Mariola Drozd; Mikołaj Zerhau; Dariusz Smoliński; Stanisław Radomiński; Natalia Cwalina; David Brindley; Miłosz J Jaguszewski; Piotr Merks
Journal:  Pharmacy (Basel)       Date:  2017-11-09

3.  The global threat of counterfeit drugs: why industry and governments must communicate the dangers.

Authors:  Robert Cockburn; Paul N Newton; E Kyeremateng Agyarko; Dora Akunyili; Nicholas J White
Journal:  PLoS Med       Date:  2005-03-14       Impact factor: 11.069

4.  Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis.

Authors:  James Prah; Elvis Ofori Ameyaw; Richmond Afoakwah; Patrick Fiawoyife; Ernest Oppong-Danquah; Johnson Nyarko Boampong
Journal:  J Trop Med       Date:  2016-02-23

Review 5.  Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations.

Authors:  Huma Rasheed; Ludwig Hoellein; Khalid Saeed Bukhari; Ulrike Holzgrabe
Journal:  J Pharm Policy Pract       Date:  2019-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.